Literature DB >> 3460994

Electron microscopic and immunohistochemical observations of differentiation of human myeloid leukemia line, PL-21.

I Kubonishi, Y Ohtsuki, T Miyagi, S Yoshimoto, T Akagi, I Miyoshi.   

Abstract

A new human myeloid leukemia cell line, PL-21, consisting of promyelocytes, was microscopically and immunohistochemically studied for their maturation induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and retinoic acid (RA). More than 80% of PL-21 cells cultured for 4 days with 10 ng/ml of TPA became macrophage-like cells with functional and histochemical properties consistent with monocytes/macrophages. The cells adhered to the plastic flask, developed phagocytic activity and macrophage-specific intracytoplasmic alpha subunit of S-100 protein, and had reduced myeloid-specific cytochemical markers. In contrast, RA-treated PL-21 cells displayed mature neutrophil-like morphology after 7 days of exposure. Most of the cells had reduced nitro blue tetrazolium and acquired phagocytic activity with persistence of myeloid-specific cytochemical markers such as peroxidase, naphthol-AS-D chloroacetate esterase, and Sudan black B. These results indicate that the PL-21 cell line ca be induced to mature into two directions of macrophages and neutrophils by chemical inducers, and will provide a useful tool for studying the differentiation of leukemic cells and searching for other differentiation inducers.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3460994     DOI: 10.1007/BF00389235

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

Authors:  H P Koeffler; D W Golde
Journal:  Science       Date:  1978-06-09       Impact factor: 47.728

2.  Induction of differentiation in human promyelocytic leukemia cells by tumor promoters.

Authors:  G Rovera; T G O'Brien; L Diamond
Journal:  Science       Date:  1979-05-25       Impact factor: 47.728

3.  Differentiation of myeloid leukaemic cells: new possibilities for therapy.

Authors:  M Baccarani; S Tura
Journal:  Br J Haematol       Date:  1979-07       Impact factor: 6.998

4.  Immunohistochemical localization and distribution of S-100 proteins in the human lymphoreticular system.

Authors:  K Takahashi; T Isobe; Y Ohtsuki; H Sonobe; I Takeda; T Akagi
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

5.  Structural relation of two S-100 proteins in bovine brain; subunit composition of S-100a protein.

Authors:  T Isobe; N Ishioka; T Okuyama
Journal:  Eur J Biochem       Date:  1981-04

6.  Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?

Authors:  M Housset; M T Daniel; L Degos
Journal:  Br J Haematol       Date:  1982-05       Impact factor: 6.998

7.  Differentiation of human leukemias in response to 12-0-tetradecanoylphorbol-13-acetate in vitro.

Authors:  L Pegoraro; J Abrahm; R A Cooper; A Levis; B Lange; P Meo; G Rovera
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

Review 8.  Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications.

Authors:  H P Koeffler
Journal:  Blood       Date:  1983-10       Impact factor: 22.113

9.  Granulocytic sarcoma presenting as a mediastinal tumor. Report of a case and cytological and cytochemical studies of tumor cells in vivo and in vitro.

Authors:  I Kubonishi; Y Ohtsuki; K Machida; Y Agatsuma; H Tokuoka; K Iwata; I Miyoshi
Journal:  Am J Clin Pathol       Date:  1984-12       Impact factor: 2.493

10.  Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid.

Authors:  T R Breitman; S J Collins; B R Keene
Journal:  Blood       Date:  1981-06       Impact factor: 22.113

View more
  1 in total

1.  Stimulatory effect of interleukin-1 beta on the interferon-gamma-dependent HLA-DR production.

Authors:  T Tomoda; T Kurashige; T Taniguchi
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.